| J3262 | Injection, tocilizumab, 1 mg | 107,650 | $10 | $538.3K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,430 | $30 | $490.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 100,800 | $1 | $403.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,670 | $30 | $173.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13,480 | $10 | $134.8K |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 3,500 | $30 | $115.5K |
| J0897 | Injection, denosumab, 1 mg | 4,740 | $20 | $90.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 560 | $100 | $54.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 510 | $70 | $36.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 490 | $50 | $25.4K |